Prostate cancer increases hyaluronan in surrounding nonmalignant stroma, and this response is associated with tumor growth and an unfavorable outcome

American Journal of Pathology

Volumn 179, Issue 4, 2011, Pages 1961-1968

  Josefsson, Andreas ^a   Adamo, Hani ^a   Hammarsten, Peter ^a   Granfors, Torvald ^a   Stattin, Pr ^a   Egevad, Lars ^b   Laurent, Anna Engström ^c   Wikström, Pernilla ^a   Bergh, Anders ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b Department of Urology   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

HYALURONIC ACID; MESSENGER RNA; SYNTHETASE;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER MODEL; CONTROLLED STUDY; GLEASON SCORE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSTATE CANCER; RAT; STROMA; TISSUE MICROARRAY; TUMOR GROWTH; TUMOR VOLUME;

AGED; AGED, 80 AND OVER; ANIMALS; CELL PROLIFERATION; GLUCURONOSYLTRANSFERASE; HUMANS; HYALURONIC ACID; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; PROSTATE; PROSTATIC NEOPLASMS; RATS; STAINING AND LABELING; STROMAL CELLS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; WATCHFUL WAITING;

EID: 80053253226     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2011.06.005     Document Type: Article

References (51)

1. O. Andren, K. Fall, L. Franzen, S.O. Andersson, J.E. Johansson, and M.A. Rubin How well does the Gleason score predict prostate cancer death? A 20-year followup of a population based cohort in Sweden J Urol 175 2006 1337 1340
2. J.I. Epstein, M. Amin, L. Boccon-Gibod, L. Egevad, P.A. Humphrey, G. Mikuz, D. Newling, S. Nilsson, W. Sakr, J.R. Srigley, T.M. Wheeler, and R. Montironi Prognostic factors and reporting of prostate carcinoma in radical prostatectomy and pelvic lymphadenectomy specimens Scand J Urol Nephrol Suppl 216 2005 34 63
3. D.A. Troyer, J. Mubiru, R.J. Leach, and S.L. Naylor Promise and challenge: markers of prostate cancer detection, diagnosis and prognosis Dis Markers 20 2004 117 128 (Pubitemid 39149920)
4. A. Bergh Characterization and functional role of the stroma compartment in prostate tumors Future Oncol 5 2009 1231 1235
5. G. Ayala, J.A. Tuxhorn, T.M. Wheeler, A. Frolov, P.T. Scardino, M. Ohori, M. Wheeler, J. Spitler, and D.R. Rowley Reactive stroma as a predictor of biochemical-free recurrence in prostate cancer Clin Cancer Res 9 2003 4792 4801 (Pubitemid 37323282)
6. N. Yanagisawa, R. Li, D. Rowley, H. Liu, D. Kadmon, B.J. Miles, T.M. Wheeler, and G.E. Ayala Stromogenic prostatic carcinoma pattern (carcinomas with reactive stromal grade 3) in needle biopsies predicts biochemical recurrence-free survival in patients after radical prostatectomy Hum Pathol 38 2007 1611 1620 (Pubitemid 47589095)
7. J.A. Tuxhorn, G.E. Ayala, M.J. Smith, V.C. Smith, T.D. Dang, and D.R. Rowley Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling Clin Cancer Res 8 2002 2912 2923 (Pubitemid 35025739)
8. H.F. Dvorak Tumors: wounds that do not heal Similarities between tumor stroma generation and wound healing N Engl J Med 315 1986 1650 1659 (Pubitemid 17052899)
9. A.M. Richardson, K. Woodson, Y. Wang, J. Rodriguez-Canales, H.S. Erickson, M.A. Tangrea, K. Novakovic, S. Gonzalez, A. Velasco, E.S. Kawasaki, M.R. Emmert-Buck, R.F. Chuaqui, and A. Player Global expression analysis of prostate cancer-associated stroma and epithelia Diagn Mol Pathol 16 2007 189 197 (Pubitemid 350196975)
10. P. Wikström, J. Marusic, P. Stattin, and A. Bergh Low stroma androgen receptor level in normal and tumor prostate tissue is related to poor outcome in prostate cancer patients Prostate 69 2009 799 809
11. I.F. Lissbrant, E. Lissbrant, J.E. Damber, and A. Bergh Blood vessels are regulators of growth, diagnostic markers and therapeutic targets in prostate cancer Scand J Urol Nephrol 35 2001 437 452 (Pubitemid 34066732)
12. I.F. Lissbrant, P. Stattin, P. Wikström, J.E. Damber, L. Egevad, and A. Bergh Tumor associated macrophages in human prostate cancer: relation to clinicopathological variables and survival Int J Oncol 17 2000 445 451
13. V. Karja, S. Aaltomaa, P. Lipponen, T. Isotalo, M. Talja, and R. Mokka Tumour-infiltrating lymphocytes: a prognostic factor of PSA-free survival in patients with local prostate carcinoma treated by radical prostatectomy Anticancer Res 25 2005 4435 4438 (Pubitemid 41729492)
14. A. Fleischmann, T. Schlomm, J. Kollermann, N. Sekulic, H. Huland, M. Mirlacher, G. Sauter, R. Simon, and A. Erbersdobler Immunological microenvironment in prostate cancer: high mast cell densities are associated with favorable tumor characteristics and good prognosis Prostate 69 2009 976 981
15. R.H. Tammi, A. Kultti, V.M. Kosma, R. Pirinen, P. Auvinen, and M.I. Tammi Hyaluronan in human tumors: pathobiological and prognostic messages from cell-associated and stromal hyaluronan Semin Cancer Biol 18 2008 288 295
16. A. Johansson, S. Rudolfsson, P. Hammarsten, S. Halin, K. Pietras, J. Jones, P. Stattin, L. Egevad, T. Granfors, P. Wikström, and A. Bergh Mast cells are novel independent prognostic markers in prostate cancer and represent a target for therapy Am J Pathol 177 2010 1031 1041
17. C. Hgglof, P. Hammarsten, A. Josefsson, P. Stattin, J. Paulson, A. Bergh, and A. Ostman Stromal PDGFRβ expression in prostate tumors and non-malignant prostate tissue predicts prostate cancer survival PLoS One 5 2010 e10747
18. L. Nonn, V. Ananthanarayanan, and P.H. Gann Evidence for field cancerization of the prostate Prostate 69 2009 1470 1479
19. S. Halin, P. Hammarsten, P. Wikström, and A. Bergh Androgen-insensitive prostate cancer cells transiently respond to castration treatment when growing in an androgen-dependent prostate environment Prostate 67 2007 370 377 (Pubitemid 46341077)
20. S. Halin, S.H. Rudolfsson, N. Van Rooijen, and A. Bergh Extratumoral macrophages promote tumor and vascular growth in an orthotopic rat prostate tumor model Neoplasia 11 2009 177 186
21. S. Halin, S.H. Rudolfsson, J.A. Doll, S.E. Crawford, P. Wikström, and A. Bergh Pigment epithelium-derived factor stimulates tumor macrophage recruitment and is downregulated by the prostate tumor microenvironment Neoplasia 12 2010 336 345
22. P. Hammarsten, A. Karalija, A. Josefsson, S.H. Rudolfsson, P. Wikström, L. Egevad, T. Granfors, P. Stattin, and A. Bergh Low levels of phosphorylated epidermal growth factor receptor in nonmalignant and malignant prostate tissue predict favorable outcome in prostate cancer patients Clin Cancer Res 16 2010 1245 1255
23. N. Itano, and K. Kimata Altered hyaluronan biosynthesis in cancer progression Semin Cancer Biol 18 2008 268 274
24. D. Jiang, J. Liang, and P.W. Noble Hyaluronan in tissue injury and repair Annu Rev Cell Dev Biol 23 2007 435 461
25. B.P. Toole, and M.G. Slomiany Hyaluronan: a constitutive regulator of chemoresistance and malignancy in cancer cells Semin Cancer Biol 18 2008 244 250
26. S. Ekici, W.H. Cerwinka, R. Duncan, P. Gomez, F. Civantos, M.S. Soloway, and V.B. Lokeshwar Comparison of the prognostic potential of hyaluronic acid, hyaluronidase (HYAL-1) CD44v6 and microvessel density for prostate cancer Int J Cancer 112 2004 121 129 (Pubitemid 39249499)
27. P. Lipponen, S. Aaltomaa, R. Tammi, M. Tammi, U. Agren, and V.M. Kosma High stromal hyaluronan level is associated with poor differentiation and metastasis in prostate cancer Eur J Cancer 37 2001 849 856 (Pubitemid 32323962)
28. S. Aaltomaa, P. Lipponen, R. Tammi, M. Tammi, J. Viitanen, J.P. Kankkunen, and V.M. Kosma Strong stromal hyaluronan expression is associated with PSA recurrence in local prostate cancer Urol Int 69 2002 266 272 (Pubitemid 35365379)
29. J.T. Posey, M.S. Soloway, S. Ekici, M. Sofer, F. Civantos, R.C. Duncan, and V.B. Lokeshwar Evaluation of the prognostic potential of hyaluronic acid and hyaluronidase (HYAL1) for prostate cancer Cancer Res 63 2003 2638 2644 (Pubitemid 36605207)
30. C.S. Gomez, P. Gomez, J. Knapp, M. Jorda, M.S. Soloway, and V.B. Lokeshwar Hyaluronic acid and HYAL-1 in prostate biopsy specimens: predictors of biochemical recurrence J Urol 182 2009 1350 1356
31. A.G. Bharadwaj, J.L. Kovar, E. Loughman, C. Elowsky, G.G. Oakley, and M.A. Simpson Spontaneous metastasis of prostate cancer is promoted by excess hyaluronan synthesis and processing Am J Pathol 174 2009 1027 1036
32. M.A. Simpson, and V.B. Lokeshwar Hyaluronan and hyaluronidase in genitourinary tumors Front Biosci 13 2008 5664 5680
33. P. Stattin, J.E. Damber, L. Karlberg, and A. Bergh Cell proliferation assessed by Ki-67 immunoreactivity on formalin fixed tissues is a predictive factor for survival in prostate cancer J Urol 157 1997 219 222 (Pubitemid 26414962)
34. M. Hellstrm, B. Johansson, and A. Engstrm-Laurent Hyaluronan and its receptor CD44 in the heart of newborn and adult rats Anat Rec A Discov Mol Cell Evol Biol 288 2006 587 592 (Pubitemid 43848028)
35. A. Josefsson, P. Wikström, T. Granfors, L. Egevad, L. Karlberg, P. Stattin, and A. Bergh Tumor size, vascular density and proliferation as prognostic markers in GS 6 and GS 7 prostate tumors in patients with long follow-up and non-curative treatment Eur Urol 48 2005 577 583 (Pubitemid 41278582)
36. V.B. Lokeshwar, D. Rubinowicz, G.L. Schroeder, E. Forgacs, J.D. Minna, N.L. Block, M. Nadji, and B.L. Lokeshwar Stromal and epithelial expression of tumor markers hyaluronic acid and HYAL1 hyaluronidase in prostate cancer J Biol Chem 276 2001 11922 11932
37. S.L. Lin, D. Chang, A. Chiang, and S.Y. Ying Androgen receptor regulates CD168 expression and signaling in prostate cancer Carcinogenesis 29 2008 282 290 (Pubitemid 351359666)
38. R. Dhir, J.T. Gau, D. Krill, S. Bastacky, R.R. Bahnson, D.L. Cooper, and M.J. Becich CD44 expression in benign and neoplastic human prostates Mol Diagn 2 1997 197 204 (Pubitemid 127734945)
39. L. Trojan, M.S. Michel, F. Rensch, D.G. Jackson, P. Alken, and R. Grobholz Lymph and blood vessel architecture in benign and malignant prostatic tissue: lack of lymphangiogenesis in prostate carcinoma assessed with novel lymphatic marker lymphatic vessel endothelial hyaluronan receptor (LYVE-1) J Urol 172 2004 103 107 (Pubitemid 41615048)
40. D. Hua, M.Y. Liu, Z.D. Cheng, X.J. Qin, H.M. Zhang, Y. Chen, G.J. Qin, G. Liang, J.N. Li, X.F. Han, and D.X. Liu Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity Mol Immunol 46 2009 2876 2884
41. B.P. Toole, A. Zoltan-Jones, S. Misra, and S. Ghatak Hyaluronan: a critical component of epithelial-mesenchymal and epithelial-carcinoma transitions Cells Tissues Organs 179 2005 66 72 (Pubitemid 40976290)
42. N. Itano, L. Zhuo, and K. Kimata Impact of the hyaluronan-rich tumor microenvironment on cancer initiation and progression Cancer Sci 99 2008 1720 1725
43. J.A. Tuxhorn, G.E. Ayala, and D.R. Rowley Reactive stroma in prostate cancer progression J Urol 166 2001 2472 2483 (Pubitemid 33065339)
44. P. Wikström, P. Stattin, I. Franck-Lissbrant, J.E. Damber, and A. Bergh Transforming growth factor beta1 is associated with angiogenesis, metastasis, and poor clinical outcome in prostate cancer Prostate 37 1998 19 29 (Pubitemid 28385181)
45. D.M. Kuang, Y. Wu, N. Chen, J. Cheng, S.M. Zhuang, and L. Zheng Tumor-derived hyaluronan induces formation of immunosuppressive macrophages through transient early activation of monocytes Blood 110 2007 587 595 (Pubitemid 47105397)
46. H. Koyama, N. Kobayashi, M. Harada, M. Takeoka, Y. Kawai, K. Sano, M. Fujimori, J. Amano, T. Ohhashi, R. Kannagi, K. Kimata, S. Taniguchi, and N. Itano Significance of tumor-associated stroma in promotion of intratumoral lymphangiogenesis: pivotal role of a hyaluronan-rich tumor microenvironment Am J Pathol 172 2008 179 193 (Pubitemid 351186379)
47. S.H. Rudolfsson, and A. Bergh Hypoxia drives prostate tumour progression and impairs the effectiveness of therapy, but can also promote cell death and serve as a therapeutic target Expert Opin Ther Targets 13 2009 219 225
48. F. Gao, P. Okunieff, Z. Han, I. Ding, L. Wang, W. Liu, J. Zhang, S. Yang, J. Chen, C.B. Underhill, S. Kim, and L. Zhang Hypoxia-induced alterations in hyaluronan and hyaluronidase Adv Exp Med Biol 566 2005 249 256 (Pubitemid 43779509)
49. S. Halin, P. Hammarsten, H. Adamo, P. Wikström, and A. Bergh Tumour indicating normal tissue (TINT) could be a novel source of diagnostic and prognostic markers for prostate cancer Exp Opin Med Diagn 5 2011 37 47
50. S.S. McAllister, and R.A. Weinberg Tumor-host interactions: a far-reaching relationship J Clin Oncol 28 2010 4022 4028
51. A. Orimo, and R.A. Weinberg Stromal fibroblasts in cancer: a novel tumor-promoting cell type Cell Cycle 5 2006 1597 1601 (Pubitemid 44285243)